Hepatitis B Annual

REVIEW ARTICLE
Year
: 2009  |  Volume : 6  |  Issue : 1  |  Page : 29--40

Management of Hepatitis B in the peri-transplant period


Sanjiv Saigal1, Amit Basnotra1, AS Soin2 
1 Department of Gastroenterology and Hepatology, Sir Ganga Ram Hospital, New Delhi, India
2 Liver Transplantation, Sir Ganga Ram Hospital, New Delhi, India

Correspondence Address:
Sanjiv Saigal
Room No. 313, Department of Gastroenterology, Sir Ganga Ram Hospital, Rajinder Nagar, New Delhi-110 060
India

Hepatitis B virus (HBV) infection is an important indication for liver transplantation worldwide. The most important concern is the prevention of viral recurrence in the post transplant period. With the introduction of Hepatitis B immunoglobulin, there has been a significance reduction in the rate of HBV recurrence with improved patient & graft survival rates. The combination of oral nucleosides along with Hepatitis B immunoglobulin has further reduced the rate of HBV recurrence, and currently the outcome of liver transplantation for HBV infection is comparable to other indications for liver transplantation.


How to cite this article:
Saigal S, Basnotra A, Soin A S. Management of Hepatitis B in the peri-transplant period.Hep B Annual 2009;6:29-40


How to cite this URL:
Saigal S, Basnotra A, Soin A S. Management of Hepatitis B in the peri-transplant period. Hep B Annual [serial online] 2009 [cited 2020 Sep 24 ];6:29-40
Available from: http://www.hepatitisbannual.org/article.asp?issn=0972-9747;year=2009;volume=6;issue=1;spage=29;epage=40;aulast=Saigal;type=0